Skip to main content
NATURECELL CO.,LTD. logo

NATURECELL CO.,LTD. — Investor Relations & Filings

Ticker · 007390 ISIN · KR7007390008 KO Manufacturing
Filings indexed 273 across all filing types
Latest filing 2022-08-18 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 007390

About NATURECELL CO.,LTD.

http://en.naturecell.co.kr/

NATURECELL CO.,LTD. is a diversified company operating across the food, beverage, cosmetics, and biotechnology sectors. The company manufactures and sells a range of products including canned goods, health functional foods, and fruit juices. In addition to its consumer goods, NATURECELL has a significant focus on its high-tech biotechnology division, which is dedicated to stem cell research and development. This division conducts clinical trials for potential therapeutic applications, with a noted emphasis on treatments for degenerative diseases such as Alzheimer's.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is an amendment (정정신고) to a previous filing. It details the adjustment of stock option grants, including the number of recipients, exercise price, and total shares. This type of disclosure regarding stock options and capital-related changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the financial authorities.
2022-08-18 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically identifies itself as a '정정신고' (Amendment Report) to a previously filed document. It details changes to stock option grants, including the number of recipients, the number of shares, and updated fair value calculations. Since this is a specific regulatory disclosure regarding equity compensation and capital structure changes that does not fit into the other specific categories like 'Director's Dealing' or 'Share Issue', it is classified as a general Regulatory Filing (RNS).
2022-08-18 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Amendment Report) to a previously filed report regarding stock option grants. In the context of corporate filings, announcements regarding the issuance of stock options or changes to capital structure (including equity-based compensation plans) are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's capital structure and potential future share issuance.
2022-08-18 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange by Naturecell. It details the issuance of stock options to employees, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the exchange.
2022-08-18 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'NatureCell' (주식회사 네이처셀) for the period of 2022-01-01 to 2022-06-30. It contains detailed financial information, business descriptions, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding major shareholders and special related parties, including collateral agreements. This type of filing is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-06-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.